FDA Approves New Eczema Drug Tested at URMC

People who suffer from eczema have new hope for relief with the U.S. Food and Drug Administration ’s approval of a “game changing” medication tested at the University of Rochester Medical Center. The new drug, Dupilumab, is the first treatment to show significant, lasting results for adults whose lives are disrupted by moderate to severe eczema or atopic dermatitis.

Source: University of Rochester Medical Center Press Releases - March 30, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news